Axcan Pharma Inc.
TSX : AXP
NASDAQ : AXCA

Axcan Pharma Inc.

November 10, 2006 10:30 ET

Axcan to Present at the Credit Suisse Healthcare Conference in Phoenix, Arizona

MONT SAINT-HILAIRE, QUEBEC--(CCNMatthews - Nov. 10, 2006) - Axcan Pharma Inc. ("Axcan" or the "Company") (TSX:AXP) (NASDAQ:AXCA) today announced that on Friday, November 17, 2006, Senior Vice President and Chief Financial Officer, Steve Gannon, will present an overview of the Company at the Credit Suisse Healthcare Conference to be held in Phoenix, AZ. This presentation will take place at 11:30 a.m. local time (1:30 p.m. Eastern time).

A webcast of Axcan's presentation will also be accessible via the Company's website at www.axcan.com.

Axcan is a leading multinational specialty pharmaceutical company focused on gastroenterology. The company develops and markets a broad line of prescription products to treat a range of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to pancreatic insufficiency. Axcan's products are marketed by its own specialized sales forces in North America and Europe. Its common shares are listed on the NASDAQ Global Market under the symbol "AXCA" and on the Toronto Stock Exchange under the symbol "AXP".

Contact Information

  • Axcan Pharma Inc.
    Isabelle Adjahi
    Director, Investor Relations
    450-467-2600 ext. 2000
    www.axcan.com